Stock listing

MXCT Stock Price, News, Filings & Events — Maxcyte, Inc.

Selected listing: MXCT · BOATS · USD · US

This page tracks Maxcyte, Inc.'s MXCT:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MXCT:BOATS. MXCT:BOATS is the stock-level entry point for investors researching Maxcyte, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maxcyte, Inc. is a public company traded on the American stock market under the ticker MXCT. The company has a market capitalization of approximately $132.83 million. Maxcyte focuses on providing cell-engineering technology and services to support the development of advanced therapies.

MXCT:BOATSUSDUSUpdated August 14, 2026
Maxcyte, Inc. logo
Ticker
MXCT:BOATS
Asset type
Stock
Market cap
$141.4M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Maxcyte, Inc. MXCT:BOATS stock context

This page tracks Maxcyte, Inc.'s MXCT:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MXCT:BOATS. MXCT:BOATS is the stock-level entry point for investors researching Maxcyte, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maxcyte, Inc. is a public company traded on the American stock market under the ticker MXCT. The company has a market capitalization of approximately $132.83 million. Maxcyte focuses on providing cell-engineering technology and services to support the development of advanced therapies.

Latest news from Maxcyte, Inc.

All Maxcyte, Inc. news →

Maxcyte, Inc. earnings calls

Research Maxcyte, Inc.

Alternate listings